Skip to content

Accu-Chek Compact System

by Roche Diagnostics Corp.

510(k) K022171

Accu-Chek Compact System is a medical device (FDA Class II; FDA product code NBW, System, Test, Blood Glucose, Over The Counter) made by Roche Diagnostics Corp., cleared under FDA 510(k) K022171 on 23 Jul 2002, active as of 22 Oct 2026. 2 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

2 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK022171 Date23 Jul 2002ClearedStatusActive

Official records

From the FDA record

Received by the FDA
3 Jul 2002
FDA decision
23 Jul 2002 (Substantially Equivalent)
FDA review time
20 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K022171 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

2 recalls · FDA

  • 2 recalls, same reason

    • Terminated Z-0977-05 FDA Unclassified (pre-2012) initiated 18 May 2005
    • Terminated Z-0976-05 FDA Unclassified (pre-2012) initiated 18 May 2005

    The meter may self-start without a sample having been applied and report erroneous results without an error message if the nose cover is not properly snapped in place and the undosed test strip is bent upwards while the meter is waiting for the sample, or if excess control solution or blood has been applied to the test strip.

Timeline

3 dated events

  1. Cleared FDA 510(k) K022171
  2. Recall initiated FDA recalls Z-0977-05
  3. Recall initiated FDA recalls Z-0976-05

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
NBW
Device class
Class II
Regulation
21 CFR Part 862.1345
Advisory committee
Clinical Chemistry
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code NBW (System, Test, Blood Glucose, Over The Counter).

Other devices from Roche Diagnostics Corp.

See all devices from Roche Diagnostics Corp. →